Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nanologica

Nanologica?uq=3Oe4kK1Z
2004 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
NICA STOCK SYMBOL
1 INVESTMENTS
$0.36 SHARE PRICE (As of Tuesday Closing)
Description

Developer of materials technology intended to solve real problems in life science. The company's materials technology focuses on synthesis and application of new porous materials and the development of industrially relevant applications.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Stock Exchange
SAT
Primary Office
  • Forskargatan 20G
  • 151 36 Sodertalje
  • Sweden

+46 08-410 000 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nanologica’s full profile, request a free trial.

Nanologica Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.29 - $1.20 $5.99M $0.36 129K

Nanologica Financials Summary

In Thousands,
USD
TTM
31-Dec-2015
FY 2015
31-Dec-2015
FY 2014
31-Dec-2014
FY 2013
31-Dec-2013
Revenue 387 387 240 349
EBITDA (1,362) (1,362) (1,918) (986)
Net Income (1,694) (1,694) (2,147) (1,544)
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nanologica Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Nanologica‘s full profile, request access.

Request full access to PitchBook

Nanologica Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000 16-May-2018 000000000 00000 Drug Discovery 0000000 00000000
To view this company’s complete investment and acquisition history, request access »

Nanologica Executive Team (5)

Name Title Board
Seat
Contact
Info
Andreas Bhagwani Chief Executive Officer
Stina Elofsson Chief Financial Officer
Nina Lanner Chief Operating Officer
Adam Feiler Chief Technology Officer & Head of Drug Delivery

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »